2.数字化精准营销决策市场销售策略与实施，大模型销售数据实时可视化分析、目标区块划分及沙盘推 演纠偏、精准敏捷的差异化政策，加上大规模人群上市后评价、孕妇、肾病综合征患者等特殊人群学术 研究，以及省市区到终端的学术推广服务覆盖准入区域的终端市场和消费者。更具针对性的数据驱动营 销方式提高了营销费用的使用效率，在支撑收入增长的同时，有助于降低销售费用; 3.公司2025年的产品发货相较于2024年进一步增加覆盖了232个疾控中心以及2,563个接种门诊，因此， 公司的接种渠道相较去年为消费者产品提供了更多区域的选择，直接推动了营业收入的增长; 4.在研发费用持续投入的基础上，公司降本增效取得初步成效，虽然2025年本集团上市费用大幅度增 加，但收入增长与成本管控收紧的综合效应使得2025财年净亏损进一步收窄。 中慧生物-B(02627)发布公告，集团预期于2025财年录得约人民币4.46亿元至人民币4.93亿元的营业收 入，较截至2024年12月31日止年度的人民币2.6亿元营业收入增加约71.8%至89.9%，并预期于2025财年 录得约人民币1.57亿元至人民币1.97亿元的净亏损，较截至2024年12月3 ...

Core Viewpoint - The banking industry is experiencing a "New Year" surge in early 2026, with small and medium-sized banks raising deposit rates despite regulatory pressures and narrowing interest margins [1][3]. Group 1: Deposit Rate Adjustments - In January, several small and medium-sized banks in regions like Shanxi, Henan, and Shaanxi have announced increases in deposit rates, with typical upward adjustments around 20 basis points (BP) [2][3]. - Specific banks, such as Shanxi Qingshui Rural Commercial Bank, have raised their deposit rates for various terms, with 1-year, 2-year, and 3-year rates reaching 1.45%, 1.50%, and 1.75% respectively [2]. - Compared to previous years, the current increases in deposit rates are less pronounced, with fewer institutions participating in the adjustments [2]. Group 2: Regulatory Environment and Market Dynamics - Regulatory authorities are promoting a market-oriented deposit rate mechanism, which has constrained banks' pricing power and reduced their motivation to raise deposit rates [3]. - The continuous narrowing of net interest margins is limiting banks' profit margins, further impacting their ability to engage in price competition [3]. Group 3: Service Enhancement Initiatives - Local banks are focusing on improving service quality, emphasizing their commitment to local communities and enhancing personalized marketing strategies [3]. - Recommendations for local banks include optimizing liability structures and developing combined deposit products to increase customer retention [3]. Group 4: Overall Market Outlook - The overall outlook for the "New Year" in January is optimistic, with many local banks reporting significant growth in their deposit and loan businesses [4][5]. - The People's Bank of China reported a total social financing increase of 35.6 trillion yuan for 2025, indicating a robust financial environment [4]. - Analysts expect that the liquidity in the market will increase, with banks experiencing a strong demand for deposits due to seasonal and structural imbalances [5].

Core Insights - The Heze Rural Commercial Bank's Xicheng Branch has effectively implemented digital marketing strategies to enhance loan marketing efforts, achieving significant results in expanding its customer base and increasing loan accounts since the beginning of the year [1] Group 1: Data Analysis and Customer Needs - The branch has established a scientific and detailed data analysis system to identify the needs of existing customers, utilizing various dimensions such as age, occupation, income level, and consumption habits to create personalized financial service plans [2] - A specific case highlighted the branch's ability to assist a customer facing cash flow issues by quickly providing tailored loan product information, which led to successful loan processing and improved business operations for the customer [2] Group 2: Digital Tools and Market Expansion - The branch has leveraged digital tools to innovate marketing methods and broaden marketing channels, resulting in rapid growth of its customer base [3] - By promoting an online loan application platform and utilizing social media for engaging promotional content, the branch has attracted a significant number of potential customers [3] - Collaborations with local business associations and hosting events like enterprise-financial matching meetings have effectively introduced loan products to small and micro enterprises, laying a solid foundation for expanding the customer market [3] - The branch has seen a steady increase in loan customer numbers, an expansion in loan scale, and an optimization of credit structure, while also enhancing service quality and market competitiveness [3] - Future plans include deepening digital transformation and continuously innovating marketing and service methods to meet diverse financial needs and contribute to local economic development [3]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [4][7]. Core Insights - The company is a leader in the medical digital marketing sector, leveraging 29 years of data assets to create a unique AI+medical platform. It has over 7 million registered users, with 2.65 million monthly active users, providing a strong foundation for value-added services to pharmaceutical companies and patients [1][12]. - The digital marketing landscape is rapidly expanding, with the market size exceeding 3 billion RMB in 2023 and a CAGR of 33.5% from 2019 to 2023. The shift towards digital marketing is driven by the need for compliance and efficiency in the medical field [2][58]. - The company has successfully monetized its large physician user base, achieving a compound annual growth rate (CAGR) of 36.8% in revenue from precision marketing and enterprise solutions from 2018 to 2024 [3][26]. Summary by Sections 1. Company Overview - The company has established itself as a leading medical information service platform, with a focus on enhancing user experience through a diverse range of products. It has developed AI products like MedAssister and MedSeeker, supported by a vast database of medical literature [1][12]. - The user base includes over 4 million registered physicians, achieving an 88% coverage rate among practicing physicians in China [12][68]. 2. Digital Marketing Industry - The digital marketing sector is witnessing significant growth, with a market size of 3 billion RMB in 2023. The industry is characterized by a shift towards compliance and efficiency, making digital marketing a preferred choice for pharmaceutical companies [2][58]. - The company’s digital marketing solutions have shown a clear advantage over traditional methods, offering better compliance, cost-effectiveness, and time efficiency [2][45]. 3. AI Empowerment - The company is leveraging AI to enhance the effectiveness of its data assets, launching products that integrate extensive medical data to improve customer acquisition and content generation [4][66]. - The forecasted net profits for 2025, 2026, and 2027 are projected to be 322 million, 364 million, and 415 million RMB, respectively, with corresponding growth rates of 2.2%, 13.2%, and 13.8% [4][6]. 4. Financial Forecast and Valuation - The company’s revenue is expected to grow from 558 million RMB in 2024 to 1.092 billion RMB in 2027, with a CAGR of 35.5% from 2024 to 2027 [6][26]. - The projected P/E ratios for 2025, 2026, and 2027 are 26, 23, and 20, respectively, indicating a favorable valuation outlook [4][6].